OakChart

Medline Inc

MDLNHealthcare·Medical Instruments & Supplies·USA·Large·NASD·Nov 11 • 3:59 PM ET

42.16+1.25 (3.06%)
2026-11-12 03:24 CET
Market cap
37,044.18 USD m
Revenue, TTM
30,680.00 USD m
Net income, TTM
569.00 USD m
Free cash flow, TTM
1,880.00 USD m
EPS diluted, TTM
0.67
P/E
63.02
Compare

Price

MDLN against its 20, 50 and 200-day averages
2050200beatmiss
35.0040.0045.0021.5M43.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MDLNclose 42.1620-day 36.0650-day 35.15200-day 39.4242.1652w low

17.1% under the 52-week high of 50.88 on 25 Feb 2026. 52-week low 31.37 on 30 Oct 2026. Last 15 sessions, 35.5% high to low

Volume 0.96× normal · the line is the 50-bar volume average

Profile

MDLN
52-week range, 55% of the way up
31.3750.88

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

IndexRUI
Employees45000
IPODec 17, 2025
ATR, 14d1.63
Rel volume0.96
Short float7.41%
Insider own41.89%
Inst own80.75%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap55.47B
Enterprise Value72.09B
Income569.00M
Sales30.68B
Book/sh13.43
Cash/sh2.74
Dividend Est.0.04 (0.09%)
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees45000
IPODec 17, 2025

Ratios

P/E63.02
Forward P/E27.17
PEG3.70
P/S1.81
P/B3.14
P/C15.37
P/FCF29.50
EV/EBITDA23.93
EV/Sales2.35
Quick Ratio2.51
Current Ratio4.04
Debt/Eq1.07
LT Debt/Eq1.06
Option/ShortYes / Yes

Earnings

EPS (ttm)0.67
EPS next Y1.55
EPS next Q0.40
EPS this Y7.77%
EPS next Y0.62%
EPS next 5Y7.35%
EPS past 3/5Y- -
Sales past 3/5Y9.85% -
EPS Y/Y TTM-57.19%
Sales Y/Y TTM11.85%
EPS Q/Q-45.65%
Sales Q/Q10.41%
EarningsNov 04 BMO
EPS/Sales Surpr.28.21% 1.74%

Ownership

Insider Own41.89%
Insider Trans-19.27%
Inst Own80.75%
Inst Trans8.26%
ROA1.48%
ROE3.93%
ROIC2.34%
Gross Margin23.44%
Oper. Margin6.46%
Profit Margin1.85%
SMA2016.90%
SMA5019.95%
SMA2006.96%
Trades-

Technical

Shs Outstand879.00M
Shs Float510.55M
Short Float7.41%
Short Ratio4.36
Short Interest37.84M
52W High50.88 -17.13%
52W Low31.37 34.40%
Volatility4.38% 3.96%
ATR (14)1.63
RSI (14)75.19
Beta-
Rel Volume0.96
Avg Volume8.68M
Volume8,313,148

Performance

Perf Week4.49%
Perf Month18.10%
Perf Quarter18.49%
Perf Half Y8.91%
Perf YTD0.38%
Perf Year-
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.62
Target Price45.38
Prev Close40.91
Price42.16
Change %3.06%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Mar 11, 2026ResumedCCitigroupBuy$60+42.3%
Feb 05, 2026InitiatedTTigress FinancialBuy$55+30.5%
Jan 21, 2026ReiteratedBBTIG ResearchBuy$50 → $55+30.5%
Jan 12, 2026InitiatedWWolfe ResearchOutperform$47+11.5%
Jan 12, 2026InitiatedWWilliam BlairOutperform
Jan 12, 2026InitiatedWWells FargoEqual Weight$42-0.4%
Jan 12, 2026InitiatedUUBSBuy$48+13.9%
Jan 12, 2026InitiatedTTruistBuy$52+23.3%
Jan 12, 2026InitiatedTTD CowenBuy$46+9.1%
Jan 12, 2026InitiatedSStifelBuy$46+9.1%

Peers

Mkt cap
TickerCompanyMkt cap
CAHCardinal Health Inc64.13B
BDXBecton Dickinson & Co58.43B
SOLVSolventum Corp15.04B
BAXBaxter International Inc13.63B
MCKMckesson Corp124.67B
ICUIICU Medical Inc4.46B
CORCencora Inc66.77B
TFXTeleflex Incorporated6.20B
HSICHenry Schein Inc9.77B
STESteris Plc24.89B

Insider trading

latest 14 of 33
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
GIC Private Ltd10% OwnerOct 08 '26Sale35.157,816,987274,767,09369,408,506Oct 13 09:25 AM
GIC Private Ltd10% OwnerOct 06 '26Sale35.057,183,013251,764,60677,225,493Oct 06 09:48 PM
GIC Private Ltd10% OwnerOct 02 '26Sale34.337,146,941245,354,48584,408,506Oct 06 09:48 PM
GIC Private Ltd10% OwnerOct 02 '26Sale35.352,570,99990,884,81520,231,483Oct 06 09:48 PM
GIC Private Ltd10% OwnerOct 06 '26Sale35.052,088,98773,218,99416,453,806Oct 06 09:48 PM
GIC Private Ltd10% OwnerOct 05 '26Sale35.781,688,69060,421,32818,542,793Oct 06 09:48 PM
GIC Private Ltd10% OwnerAug 13 '26Sale35.801,500,00053,700,00022,902,482Aug 17 04:15 PM
GIC Private Ltd10% OwnerAug 14 '26Sale35.80100,0003,580,00022,802,482Aug 17 04:15 PM
GIC Private Ltd10% OwnerAug 07 '26Sale35.58590,28421,002,30524,402,482Aug 11 09:03 AM
GIC Private Ltd10% OwnerAug 05 '26Sale35.601,976,61870,361,90025,264,760Aug 07 04:15 PM
GIC Private Ltd10% OwnerAug 06 '26Sale35.33271,9949,609,54824,992,766Aug 07 04:15 PM
Golwas Douglas PChief Commercial OfficerJun 16 '26Sale36.77100,0003,677,11523,899Jun 17 04:44 PM
Douglas GolwasOfficerJun 16 '26Proposed Sale36.50100,0003,650,000Jun 16 12:33 PM
CORCORAN JESSI LPrincipal Accounting OfficerJun 05 '26Buy34.155,000170,7505,000Jun 09 04:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTVVanguard Morningstar Value ETFAUM: 196.23B
VOEVanguard Morningstar Mid-Cap Value ETFAUM: 24.66B
EAGLEagle Capital Select Equity ETFAUM: 4.93B
IWRiShares Russell Mid-Cap ETFAUM: 58.68B
CGUSCapital Group Core Equity ETFAUM: 12.20B
IWDiShares Russell 1000 Value Index FundAUM: 84.71B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.4400.3430.2207,8567,72224
2026Q22026-08-050.5000.3520.0707,6857,51925
2026Q12026-05-060.3300.2950.1567,3527,16326
2025Q42026-02-250.2250.2380.2247,7877,51222
2025Q32025-12-030.311-0.4037,115--
2026Q4--0.398--8,49925
2027Q1--0.343--7,88218
2027Q2--0.383--8,32818
2027Q3--0.400--8,48718
2027Q4--0.444--9,23917
2028Q1--0.384--8,4875
2028Q2--0.424--8,9765
2028Q3--0.472--9,1705
2028Q4--0.514--9,8825

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY1.4311.2030.89528,43228,157
2026FY-1.542--31,386
2027FY-1.552--33,920
2028FY-1.770--36,559
2029FY-2.054--39,441
2030FY-2.312--42,380

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1023118,4998,4068,681
2026Q4S2026-11-0923118,4988,4068,681
2026Q4S2026-11-0623118,4968,4068,681
2026Q4S2026-11-0423118,4958,4068,681
2026Q4S2026-10-2123028,4718,3688,552
2026Q4S2026-10-1923028,4738,3688,552
2026Q4S2026-10-0923048,4738,3688,552
2026Q4S2026-10-0523048,4748,3688,552
2026Q4S2026-10-0123048,4748,3688,552
2026Q4S2026-09-2223038,4808,3688,553
2026Q4S2026-08-1123028,4848,3808,553
2026Q4S2026-08-1023028,4828,3808,553
2026Q4S2026-08-0723028,4828,3808,553
2026Q4S2026-08-0623028,4818,3808,553

Estimate history

EPS, annual-0.0310.2931.51.4270.669
Period2022202320242025TTM
EPS, quarterly0.4050.3610.4030.4160.4030.2240.1560.070.219
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2144823231255072843230680
Period2022202320242025TTM
Sales, quarterly638867846644688671157787735276857856
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual799.8799.8799.8812879
Period2022202320242025MRQ
Shares, quarterly799.8799.8799.8799.8799.8812846877879
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Total Revenue30,680.0028,432.0025,507.0023,231.0021,448.00
Cost of Goods Sold Incl. D&A23,490.0021,618.0019,216.0018,008.0016,891.00
Gross Profit7,190.006,814.006,291.005,223.004,557.00
Selling, General and Administrative Excl. Other4,886.004,499.004,108.003,867.003,676.00
Research and Development-80.0067.0060.0058.00
Other Operating Expense321.0078.00-42.00-88.0011.00
Operating Income1,983.002,237.002,225.001,444.00870.00
Interest Expense829.001,028.001,309.001,375.00911.00
Unusual Expense711.0092.0083.00161.00-9.00
Net Income Before Taxes1,118.001,248.001,246.00264.0010.00
Income Taxes242.0091.0046.0030.0035.00
Consolidated Net Income879.001,157.001,200.00234.00-25.00
Net Income From Continuing Operations569.001,159.001,200.00234.00-25.00
Net Income569.001,159.001,200.00234.00-25.00
EPS (Recurring)0.881.511.570.43-0.04
EPS (Basic, Before Extraordinaries)0.681.431.500.29-0.03
EPS (Diluted)0.671.431.500.29-0.03
EBITDA3,013.003,248.003,202.002,395.001,803.00
Non-Operating Income (Expense)675.00131.00413.00356.0042.00
Other After Tax Adjustments3.000.000.000.000.00
Stock Option Compensation Expense85.3262.4148.1961.6250.56
Price To Earnings Ratio63.0263.0226.48--
Price To Sales Ratio1.491.20---
Gross Margin23.4423.9724.6622.4821.25
Operating Margin6.467.878.726.224.06
Net Margin1.854.084.701.01-0.12
Shares Outstanding879.00812.00799.80799.80799.80
Market Capitalization37,044.1837,044.1833,527.62--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue7,856.007,685.007,352.007,787.007,115.006,886.006,644.006,784.00
Cost of Goods Sold Incl. D&A6,107.005,647.005,687.006,049.005,417.005,157.004,995.005,110.00
Gross Profit1,749.002,038.001,665.001,738.001,698.001,729.001,649.001,674.00
Selling, General and Administrative Excl. Other1,229.001,266.001,163.001,228.001,116.001,086.001,100.001,164.00
Other Operating Expense-90.00348.0015.0048.008.0014.00-42.00-61.00
Operating Income610.00424.00487.00462.00574.00629.00591.00571.00
Interest Expense155.00159.00162.00353.00228.00233.00214.00545.00
Unusual Expense121.00420.0075.0095.006.00-13.00-62.0048.00
Net Income Before Taxes386.00235.00291.00206.00345.00359.00338.00305.00
Income Taxes68.0096.0052.0026.0023.0026.0016.0016.00
Consolidated Net Income321.00139.00239.00180.00322.00333.00322.00289.00
Net Income From Continuing Operations198.0060.00129.00182.00322.00333.00322.00289.00
Net Income198.0060.00129.00182.00322.00333.00322.00289.00
EPS (Recurring)0.280.410.220.310.410.400.350.40
EPS (Basic, Before Extraordinaries)0.230.070.160.220.400.420.400.36
EPS (Diluted)0.220.070.160.220.400.420.400.36
EBITDA869.00680.00741.00723.00827.00879.00838.00824.00
Non-Operating Income (Expense)52.00390.0041.00192.005.00-50.00-101.00327.00
Other After Tax Adjustments3.000.000.000.000.000.000.000.00
Stock Option Compensation Expense22.9122.9118.1721.3311.8511.8517.388.69
Price To Earnings Ratio63.0232.9930.7826.5326.48---
Price To Sales Ratio1.491.121.171.20----
Gross Margin22.2626.5222.6522.3223.8725.1124.8224.68
Operating Margin7.765.526.625.938.079.138.908.42
Net Margin2.520.781.752.344.534.844.854.26
Shares Outstanding879.00877.00846.00812.00799.80799.80799.80799.80
Market Capitalization37,044.1833,350.7036,118.3434,079.5633,527.62---

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY
Cash & Short Term Investments1,942.00250.001,585.00-
Short Term Receivables3,533.003,219.002,960.00-
Inventories4,769.004,456.003,813.00-
Other Current Assets435.00347.00451.00-
Total Current Assets10,679.008,272.008,809.00-
Net Property, Plant & Equipment5,210.004,979.004,797.00-
Total Investments and Advances0.0048.0086.00-
Intangible Assets21,972.0022,624.0022,320.00-
Deferred Tax Assets583.00---
Other Assets40.0055.00110.00-
Total Assets38,484.0035,978.0036,122.00-
Short Term Debt Incl. Current Port. of LT Debt143.00154.00122.00-
Accounts Payable961.00869.00696.00-
Income Tax Payable24.004.009.00-
Other Current Liabilities1,362.001,413.001,304.00-
Total Current Liabilities2,490.002,440.002,131.00-
Long Term Debt12,870.0016,745.0016,706.00-
Provision for Risks Charges0.000.000.00-
Other Liabilities3,838.00269.00308.00-
Total Liabilities19,198.0019,454.0019,145.00-
Non-Equity Reserves0.000.000.00-
Preferred Stock - Carrying Value0.00366.00233.00-
Common Equity10,737.0016,158.0016,744.00-
Total Shareholders Equity10,737.0016,524.0016,977.00-
Accumulated Minority Interest8,549.000.000.00-
Total Equity19,286.0016,524.0016,977.00-
Total Liabilities & Stockholders Equity38,484.0035,978.0036,122.00-
Book Value Per Share13.2220.2020.94-
Tangible Book Value Per Share-13.84-8.08-6.97-
Full-Time Employees45,00043,000--
Price to Book Ratio3.142.00--
Return on Assets3.113.33--
Return on Equity8.507.16--
Return on Invested Capital4.913.610.69-
Quick Ratio2.371.562.34-
Current Ratio4.293.394.13-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Net Income876.001,157.001,200.00234.00-25.00
Depreciation1,030.001,011.00977.00951.00933.00
Other Funds (Non Cash)512.00359.00291.00325.00212.00
Funds from Operations2,558.002,527.002,444.001,486.001,106.00
Extraordinary Item0.000.000.000.000.00
Changes in Working Capital-177.00-783.00-675.00199.00-919.00
Cash from Operating Activities2,381.001,744.001,769.001,685.00187.00
Capital Expenditures-501.00-480.00-364.00-285.00-254.00
Net Assets From Acquisitions-6.000.00-1,126.00-16.00-17.00
Sale of Fixed Assets and Businesses6.006.000.000.000.00
Purchase or Sale of Investments-1,274.000.000.00-11.007.00
Purchase of Investments-1,274.000.000.00-16.000.00
Sale Or Maturity of Investments0.000.000.005.007.00
Other Uses0.000.00-3.000.000.00
Other Sources100.000.000.000.000.00
Cash from Investing Activities-1,675.00-474.00-1,493.00-312.00-264.00
Cash Dividends Paid0.000.000.000.000.00
Change in Capital Stock5,039.005,009.00-20.000.000.00
Repurchase of Common Pref Stock0.00-33.00-20.000.000.00
Sale of Common Pref Stock5,039.005,042.000.000.000.00
Proceedsfrom Stock Options5,030.005,042.000.000.000.00
Issuance or Reduction of Debt, Net-4,097.00-4,092.00-75.00-77.00-61.00
Change in Long Term Debt-4,097.00-4,092.00-75.00-77.00-61.00
Issuance of Long Term Debt4,730.007,748.0016,086.000.0080.00
Reduction of Long Term Debt-8,827.00-11,840.00-16,161.00-77.00-141.00
Net Financing Active Other Cash Flow-265.00-518.00-1,518.00-114.00-23.00
Other Financing Activities Uses-265.00-518.00-1,518.00-114.00-23.00
Cash from Financing Activities677.00399.00-1,613.00-191.00-84.00
Exchange Rate Effect-15.0023.002.004.00-30.00
Net Change in Cash1,368.001,692.00-1,335.001,186.00-191.00
Free Cash Flow1,880.001,264.001,405.001,400.00-67.00
Preferred Dividends (Cash Flow)-0.000.000.000.00
Price to Free Cash Flow24.3026.98---
Deferred Taxes & Investment Tax Credit-0.00-24.00-24.00-14.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments3,610.002,679.002,238.001,942.00955.00584.00
Short Term Receivables3,794.003,661.003,674.003,533.003,425.003,340.00
Inventories4,806.004,665.004,807.004,769.004,752.004,662.00
Other Current Assets443.00737.00461.00435.00426.00361.00
Total Current Assets12,653.0011,742.0011,180.0010,679.009,558.008,947.00
Net Property, Plant & Equipment4,728.004,697.004,758.005,210.004,690.004,672.00
Total Investments and Advances0.000.000.000.0011.0019.00
Intangible Assets21,450.0021,610.0021,793.0021,972.0022,137.0022,315.00
Deferred Tax Assets833.00866.00837.00583.00--
Other Assets514.00435.00446.0040.00487.00475.00
Total Assets40,178.0039,350.0039,014.0038,484.0036,883.0036,428.00
Short Term Debt Incl. Current Port. of LT Debt97.0092.00142.00143.00149.00145.00
Accounts Payable1,209.001,043.00932.00961.00990.00919.00
Income Tax Payable-16.0036.0024.0031.0023.00
Other Current Liabilities1,823.001,559.001,426.001,362.001,442.001,264.00
Total Current Liabilities3,129.002,710.002,536.002,490.002,612.002,351.00
Long Term Debt12,551.0012,548.0012,495.0012,870.0016,501.0016,501.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities5,112.005,015.004,634.003,838.00629.00625.00
Total Liabilities20,792.0020,273.0019,665.0019,198.0019,742.0019,477.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.00367.00367.00
Common Equity11,801.0011,572.0011,272.0010,737.0016,774.0016,584.00
Total Shareholders Equity11,801.0011,572.0011,272.0010,737.0017,141.0016,951.00
Accumulated Minority Interest7,585.007,505.008,077.008,549.000.000.00
Total Equity19,386.0019,077.0019,349.0019,286.0017,141.0016,951.00
Total Liabilities & Stockholders Equity40,178.0039,350.0039,014.0038,484.0036,883.0036,428.00
Book Value Per Share13.4313.1913.3213.2220.9720.74
Tangible Book Value Per Share-10.98-11.45-12.44-13.84-6.71-7.17
Full-Time Employees---45,000--
Price to Book Ratio3.142.963.372.002.00-
Return on Assets1.481.83-3.11--
Return on Equity3.934.86-8.50--
Return on Invested Capital0.810.250.540.770.961.00
Quick Ratio2.512.612.512.371.841.82
Current Ratio4.044.334.414.293.663.81

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income318.00139.00239.00180.00322.00333.00
Depreciation259.00256.00254.00261.00253.00244.00
Other Funds (Non Cash)-20.00419.0043.0070.0060.00169.00
Funds from Operations596.00878.00573.00511.00635.00746.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital429.00-163.00-161.00-282.001.00-503.00
Cash from Operating Activities1,025.00715.00412.00229.00636.00243.00
Capital Expenditures-156.00-111.00-96.00-138.00-101.00-140.00
Net Assets From Acquisitions0.000.000.00-6.000.00-
Sale of Fixed Assets and Businesses0.000.000.006.000.000.00
Purchase or Sale of Investments-924.00-350.000.000.000.000.00
Purchase of Investments-924.00-350.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources100.000.000.000.000.000.00
Cash from Investing Activities-980.00-461.00-96.00-138.00-101.00-134.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.00-3.005,042.00-18.003.00
Repurchase of Common Pref Stock0.000.000.000.00-18.003.00
Sale of Common Pref Stock0.000.00-3.005,042.000.000.00
Proceedsfrom Stock Options-8.00-1.00-3.005,042.000.000.00
Issuance or Reduction of Debt, Net-7.00-41.000.00-4,049.00-24.005.00
Change in Long Term Debt-7.00-41.000.00-4,049.00-24.005.00
Issuance of Long Term Debt0.004,730.000.000.007,569.00-7,390.00
Reduction of Long Term Debt-7.00-4,771.000.00-4,049.00-7,593.007,395.00
Net Financing Active Other Cash Flow-41.00-118.00-10.00-96.00-119.00-184.00
Other Financing Activities Uses-41.00-118.00-10.00-96.00-119.00-184.00
Cash from Financing Activities-48.00-159.00-13.00897.00-161.00-176.00
Exchange Rate Effect-3.00-4.00-7.00-1.00-3.0030.00
Net Change in Cash-6.0091.00296.00987.00371.00-37.00
Free Cash Flow869.00604.00316.0091.00535.00103.00
Price to Free Cash Flow24.3021.6432.6526.98--

Revenue breakdown

Non-US2024: 1.76B 2025: 1.95B
United States2024: 23.75B 2025: 26.48B
Medline Brand2024: 12.52B 2025: 13.72B
Supply Chain Solutions2024: 12.99B 2025: 14.71B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.41%37.8M510.6M8.49M
2026-10-158.01%40.8M509.8M7.63M
2026-09-3010.33%52.7M509.8M7.46M
2026-09-158.10%41.3M509.8M7.33M
2026-08-317.74%39.5M509.8M8.27M
2026-08-147.29%36.2M496.0M9.85M
2026-07-316.17%34.6M560.3M9.61M
2026-07-155.45%29.5M540.0M9.66M
2026-06-306.72%36.3M539.9M9.60M
2026-06-155.18%27.6M533.2M9.17M
2026-05-294.33%22.8M525.3M8.80M
2026-05-154.56%22.3M487.8M6.74M
2026-04-303.93%18.4M467.4M5.86M
2026-04-153.99%18.7M467.4M5.55M
2026-03-314.88%21.9M450.0M5.33M
2026-03-132.57%11.6M450.0M7.10M
2026-02-271.82%8.2M450.0M6.49M
2026-02-131.62%7.3M449.9M7.29M
2026-01-301.57%6.8M435.5M8.81M
2026-01-151.43%6.0M418.3M11.72M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call17.5022.8026.7018.405.8194.000.000.992-0.0220.001
call20.0020.3024.2015.605.08110.000.000.991-0.0220.002
call22.5017.9021.7014.204.4408.000.000.989-0.0220.002
call25.0015.4018.800.003.5570.000.000.987-0.0220.002
call27.5012.9016.7010.403.35219.000.000.985-0.0220.002
call30.0010.4013.9011.002.6862.000.000.960-0.0450.006
call32.507.9010.708.001.8241560.000.951-0.0430.007
call35.006.209.106.601.9531,1371020.938-0.0400.008
call37.504.505.003.750.6992,6270.000.822-0.0890.017
call40.001.802.751.750.5421,69427.000.745-0.0700.021
call42.500.151.001.020.43624629.000.492-0.0980.026
call45.000.100.250.150.42318,24116.000.218-0.0560.019
call47.500.000.100.250.4982240.000.071-0.0250.009
call50.000.000.900.050.6641650.000.056-0.0280.007
call55.000.000.250.500.9441,1150.000.042-0.0320.006
call60.000.000.050.261.08612.000.000.020-0.0180.003
call65.000.001.000.751.2621.000.000.018-0.0210.003
call70.000.002.150.001.4400.000.000.016-0.0210.003
put17.500.001.750.002.5560.000.00-0.008-0.0210.001
put20.000.000.950.182.1971.000.00-0.009-0.0200.002
put22.500.000.050.061.71421.000.00-0.012-0.0180.002
put25.000.000.050.021.5932,1810.00-0.013-0.0190.002
put27.500.000.050.051.1922,4160.00-0.016-0.0170.003
put30.000.000.200.021.3276,4860.00-0.040-0.0420.006
put32.500.000.750.051.0654,6840.00-0.048-0.0400.007
put35.000.000.150.080.8141,1211.00-0.062-0.0370.008
put37.500.050.600.100.8891,62012.00-0.178-0.0850.017
put40.000.350.550.450.5655,7111,243-0.255-0.0660.021
put42.500.102.501.340.89515.001,568-0.508-0.0940.026
put45.001.904.1010.940.90832.000.00-0.782-0.0510.019
put47.503.406.600.001.1890.000.00-0.929-0.0200.009
put50.006.909.709.611.7020.000.00-0.944-0.0230.007
put55.0011.9014.700.002.1340.000.00-0.958-0.0260.006
put60.0016.8019.600.002.4480.000.00-0.979-0.0130.003
put65.0021.8024.600.002.7600.000.00-0.982-0.0130.003
put70.0026.9029.600.003.0360.000.00-0.984-0.0140.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-06SCHEDULE 13G/ASEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-26SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-218-KCurrent report2026-10-21SEC
2026-10-158-KCurrent report2026-10-13SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-08SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-11SCHEDULE 13G/ASEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-07SCHEDULE 13G/ASEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-06SCHEDULE 13GSEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-27SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-098-KCurrent report2026-07-07SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-16144Filing for proposed sale of securities under Rule 144.SEC
2026-06-154Statement of changes in beneficial ownership of securities2025-12-16SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1000996.41M6
2026-090000
2026-0800158.25M5
2026-070000
2026-06170.75K13.68M1
2026-05003.60B3
2026-040000
2026-03007.60B7
2026-020000
2026-010000
2025-12514.80M32.51B6
2025-110000

Institutional holders

Manager% owned
Carlyle Group Inc.21.32%
Blackstone Inc.12.04%
H&F Corporate Investors X, Ltd.8.08%
FMR LLC5.06%
Capital Research Global Investors4.73%
Invesco Ltd.4.53%
BlackRock, Inc.3.12%
MORGAN STANLEY2.56%
LONE PINE CAPITAL LLC2.48%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2.35%

Funds

Fund% owned
AMCAP Fund2.14%
Fidelity Contrafund1.66%
Growth Fund of America1.58%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.47%
VANGUARD MID-CAP INDEX FUND1.00%
MFS Value Fund0.78%
Janus Henderson Forty Fund0.70%
Investment Co of America0.62%
VANGUARD EXTENDED MARKET INDEX FUND0.55%
VANGUARD U.S. GROWTH FUND0.50%

OakChart. MDLN. Cached 15 minutes.